Position in BSX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,859
-$9,000 QoQ
Shares Held
67
-64.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,399
of 1,464 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $3,169,435 across 7 Medical Devices names. BSX ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
3,426 | $1,078,641 | |
| 2 | ABT |
Abbott Laboratories
|
10,955 | $994,056 | |
| 3 | MDT |
Medtronic plc
|
12,480 | $976,310 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
1,637 | $104,784 | |
| 5 | TMDX |
TransMedics Group, Inc.
|
150 | $9,963 | |
| 6 | BSX |
Boston Scientific Corp
This page
|
67 | $2,859 | |
| 7 | PRCT |
PROCEPT BioRobotics Corp
|
125 | $2,822 |
All Filings in BSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,859 | 67 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $11,859 | 189 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,574 | 27 | Shares | Sole | 2026-02-12 | |
| 2024-09-30 | $9,553 | 114 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,779 | 114 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $5,821 | 85 | Shares | Sole | 2024-05-07 | |
| 2023-03-31 | $157,594 | 3,150 | Shares | Sole | 2023-05-16 | |
| 2022-06-30 | $7,528 | 202 | Shares | Sole | 2022-08-16 | |
| 2021-12-31 | $8,580 | 202 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||